Progyny, Inc. - Common Stock (OQ:PGNY)

Apr 17, 2024 09:23 am ET
Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and Fertility Matters Canada, a national fertility patient-focused organization, today announced both organizations will be co-hosting...
Apr 04, 2024 08:59 am ET
Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast
Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and RESOLVE: The National Infertility Association today announced a series of nationwide events to commemorate National Infertility...
Mar 18, 2024 12:00 pm ET
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in...
Mar 11, 2024 12:00 pm ET
Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Michael Sturmer, Progyny’s President, will participate in a...
Feb 29, 2024 07:30 am ET
Progyny, Inc. Announces Share Repurchase Program
Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, announced today that its Board of Directors has approved a share repurchase program to repurchase up to $100 million of its common...
Feb 27, 2024 04:01 pm ET
Progyny, Inc. Announces Fourth Quarter 2023 Results
Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the three- and twelve-month periods ended December 31, 2023 (“the...
Feb 13, 2024 04:30 pm ET
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2023 Results Report
Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2023 after the close of the market on...
Jan 17, 2024 08:30 am ET
Vistia Health selects Progyny as its preferred fertility and family building benefits provider
Vistia Health brings Progyny's comprehensive suite offertility and family building services to its clients
Jan 11, 2024 09:01 am ET
Progyny Expands its Leadership Team
Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced two newly created roles with the appointment of Katie Higgins as Chief Commercial Officer and Steven Leist as Chief...
Jan 08, 2024 10:30 am ET
Progyny, Inc. to Present at 42nd Annual J.P. Morgan Healthcare Conference
Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on...
Nov 10, 2023 12:00 pm ET
Progyny, Inc. to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial...
Nov 07, 2023 04:05 pm ET
Progyny, Inc. Announces Third Quarter 2023 Results
Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended September 30,...
Nov 01, 2023 09:00 am ET
The Broken Brown Egg and Progyny Launch 2023 Awareness, Hope, and Activism Grant™ to Help BIPOC Individuals and Couples Expand Their Families
Progyny, Inc (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, and The Broken Brown Egg, a nonprofit supporting BIPOC individuals and couples experiencing infertility, today...
Oct 24, 2023 02:00 pm ET
Progyny, Inc. Announces Details for Its Third Quarter 2023 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended September 30, 2023 after the close of the market...
Aug 22, 2023 11:56 am ET
Progyny Celebrates More Than 30,000 Amazonians Supported on Their Family Building Journeys
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced their nearly five-year partnership with Amazon has reached a milestone number of more than 30,000...
Aug 04, 2023 09:01 am ET
Progyny Unveils Nationwide Access to Menopause Care
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced the strategic expansion of its extensive managed reproductive health network to include...
Aug 03, 2023 04:01 pm ET
Progyny, Inc. Announces Second Quarter 2023 Results
Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended June 30, 2023...
Jul 20, 2023 12:00 pm ET
Progyny, Inc. Announces Details for Its Second Quarter 2023 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended June 30, 2023 after the close of the market on...
Jun 29, 2023 08:30 am ET
Quantum Health Partners With Progyny To Launch New Family-Building Benefits Offering
Quantum Health, the leading consumer healthcare navigation and care coordination company, announced today it has partnered with Progyny, Inc. (Nasdaq: PGNY) as part of its launch of a new family-building benefits offering to help employers provide a better, more comprehensive and inclusive experience for all employees who need support to build their f
Jun 05, 2023 12:00 pm ET
Progyny, Inc. to Present at Jefferies 2023 Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial...
May 08, 2023 04:03 pm ET
Progyny, Inc. Announces First Quarter 2023 Results
Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended March 31, 2023...
May 02, 2023 12:00 pm ET
Progyny, Inc. to Present at Bank of America Health Care Conference 2023
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, Mark Livingston, Chief Financial Officer,...
Apr 24, 2023 12:00 pm ET
Progyny, Inc. Announces Details for Its First Quarter 2023 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended March 31, 2023 after the close of the market on...
Apr 19, 2023 11:10 am ET
Progyny and Fertility Matters Canada Honour Canadian Fertility Awareness Week with a Call to Increase Access to Family Building Care
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, and Fertility Matters Canada, a national fertility patient-focused organization, today announced both...
Apr 18, 2023 09:00 am ET
Progyny and RESOLVE to Honor National Infertility Awareness Week® by Lighting the Empire State Building and Ringing the Nasdaq Stock Market Closing Bell
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, in its capacity as an official partner for National Infertility Awareness Week 2023, and RESOLVE: The National...
Apr 04, 2023 09:00 am ET
Progyny Appoints Janet Choi, M.D., as Chief Medical Officer
Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced the appointment of Janet Choi, M.D., as the company's Chief Medical Officer. Dr. Choi brings more...
Mar 22, 2023 09:00 am ET
Children’s Hospital Association Selects Progyny as Exclusive Partner for Fertility and Family Building Benefits
Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, announced today its partnership with Children’s Hospital Association (CHA), a national voice for more than 220...
Mar 20, 2023 12:00 pm ET
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial...
Mar 14, 2023 09:00 am ET
Progyny Enhances Male Fertility Offering with the Expansion of its Reproductive Urologist Network
Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced the expansion of its provider network to include reproductive urologists (RU). Patients with...
Mar 09, 2023 07:49 pm ET
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation – PGNY
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDAQ: PGNY) resulting from allegations that Progyny may have issued materially misleading...
Mar 01, 2023 05:40 pm ET
NATIONALLY RANKED ROSEN LAW FIRM Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation – PGNY
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDAQ: PGNY) resulting from allegations that Progyny may have issued materially misleading business information to the investing public.
Mar 01, 2023 09:00 am ET
Detroit Pistons Become First Professional Sports Team in the United States to Partner with Progyny to Provide Comprehensive, Value-Based Family Building Care
Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced a partnership with the National Basketball Association’s Detroit Pistons. Through this partnership,...
Feb 28, 2023 07:44 pm ET
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation – PGNY
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDAQ: PGNY) resulting from allegations that Progyny may have issued materially misleading...
Feb 27, 2023 04:03 pm ET
Progyny, Inc. Announces Fourth Quarter 2022 Results
Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three- and twelve-month periods ended...
Feb 13, 2023 04:44 pm ET
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2022 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period and full year ended December 31, 2022 after the close...
Feb 08, 2023 09:00 pm ET
PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY) on behalf of Progyny stockholders. Our investigation concerns...
Feb 07, 2023 10:09 am ET
PGNY Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Progyny, Inc. for Potential Securities Law Violations
The law firm of Wohl & Fruchter LLP is investigating whether Progyny, Inc. (Nasdaq: PGNY) (“Progyny”) has violated federal securities laws based on a new report by Spruce Point Capital Management alleging improper revenue recognition policies. If...
Feb 07, 2023 12:25 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
NEW YORK, Feb. 7, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Feb 04, 2023 05:06 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Jan 21, 2023 10:37 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Jan 09, 2023 08:00 am ET
Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor Conference
Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that the Company is participating in the 41st Annual JP Morgan...
Jan 01, 2023 09:48 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Dec 28, 2022 11:40 pm ET
PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY) on behalf of Progyny stockholders. Our investigation concerns...
Dec 26, 2022 03:30 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
NEW YORK, Dec. 26, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Dec 24, 2022 09:08 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Dec 23, 2022 09:23 pm ET
PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY) on behalf of Progyny stockholders. Our investigation concerns...
Dec 19, 2022 09:35 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
NEW YORK, Dec. 19, 2022 /PRNewswire/ -- (ACCESSWIRE) Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY).  Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Dec 19, 2022 08:50 pm ET
PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY) on behalf of Progyny stockholders. Our investigation concerns...
Dec 16, 2022 05:10 pm ET
NATIONALLY RANKED ROSEN LAW FIRM Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation – PGNY
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDAQ: PGNY) resulting from allegations that Progyny may have issued materially misleading...
Dec 15, 2022 10:00 am ET
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Progyny, Inc. and Encourages Investors with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Progyny, Inc. (“Progyny” or “the Company”) (NASDAQ:
Dec 10, 2022 04:55 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Progyny, Inc. and Encourages Investors with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Progyny, Inc. (“Progyny” or “the Company”) (NASDAQ:
Dec 08, 2022 05:53 pm ET
PGNY INVESTOR NOTICE: Rosen Law Firm Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation – PGNY
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Progyny, Inc. (NASDAQ: PGNY) resulting from allegations that Progyny may have issued materially misleading business information to the investing public.
Dec 07, 2022 09:28 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Nov 28, 2022 08:00 am ET
Progyny Raises 2022 Financial Guidance
Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that it is raising its financial guidance for the fourth quarter and...
Nov 04, 2022 12:00 pm ET
Progyny, Inc. to Present at Credit Suisse 31st Annual Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial...
Nov 03, 2022 04:01 pm ET
Progyny, Inc. Announces Third Quarter 2022 Results
Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended September 30,...
Oct 18, 2022 01:05 pm ET
Progyny, Inc. Announces Details for Its Third Quarter 2022 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended September 30, 2022 after the close of the market...
Sep 09, 2022 10:00 am ET
Progyny, Inc. to Present at the BofA Securities 2022 Global Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial...
Sep 06, 2022 03:00 pm ET
Progyny Strengthens Board of Directors with Appointment of Healthcare Leader and Advocate
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced the appointment of a new member to its board of directors, effective August 30, 2022. Joining the...
Aug 04, 2022 04:05 pm ET
Progyny, Inc. Announces Second Quarter 2022 Results
Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended June 30, 2022...
Jul 27, 2022 08:00 am ET
Progyny is First Fertility Benefits Solution to Publish Outcomes with Independent Validation
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Progyny is the first, and only, fertility benefits solution to publicly publish its clinical...
Jul 25, 2022 11:29 am ET
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Progyny, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
NEW YORK, July 25, 2022 /PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Progyny, Inc. (NASDAQ: PGNY).
Jul 21, 2022 04:13 pm ET
Progyny, Inc. Announces Details for Its Second Quarter 2022 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended June 30, 2022 after the close of the market on...
Jun 01, 2022 03:42 pm ET
PGNY STOCKHOLDER ALERT: Robbins LLP Reminds Investors it is Investigating Progyny, Inc. (PGNY) on Behalf of Shareholders
Shareholder rights law firm Robbins LLP announces that it is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors breached fiduciary duties to shareholders. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the Uni
Jun 01, 2022 03:00 pm ET
Progyny, Inc. to Present at the Jefferies 2022 Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston,...
Jun 01, 2022 06:00 am ET
SHAREHOLDER ALERT: Morris Kandinov Investigating STON, HMTV, PGNY, and CCOI; Shareholders are Encouraged to Contact the Firm
National law firm Morris Kandinov is investigating the actions of the officers and board of directors of StoneMor Inc., Hemisphere Media Group, Inc., Progyny, Inc., and Cogent Communications Holdings, Inc.   If you are a current owner of shares of...
May 24, 2022 09:00 am ET
Progyny Lands Employer Benefits Expert in Expansion of Leadership Team
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced the expansion of its leadership team. Arielle Bogorad, formerly from Cerner...
May 18, 2022 03:43 am ET
PGNY STOCK NEWS: Robbins LLP Investigates Progyny, Inc. (PGNY) on Behalf of Shareholders
Shareholder rights law firm Robbins LLP announces that it is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors breached fiduciary duties to shareholders. Progyny, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United St
May 06, 2022 12:06 pm ET
The Broken Brown Egg and Progyny Launch the Awareness, Hope, and Activism Grant™ to Help BIPOC Individuals and Couples Expand their Families
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, and The Broken Brown Egg, a nonprofit supporting BIPOC individuals and couples experiencing...
May 05, 2022 04:05 pm ET
Progyny, Inc. Announces First Quarter 2022 Results
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three-month period ended March 31, 2022 (“the...
Apr 28, 2022 05:00 pm ET
Progyny, Inc. to Present at the BofA Securities 2022 Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced executives from Progyny will participate in a fireside chat at the BofA...
Apr 21, 2022 03:25 pm ET
Progyny, Inc. Announces Details for Its First Quarter 2022 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended March 31, 2022 after the...
Apr 19, 2022 09:00 am ET
Progyny and RESOLVE to Launch National Infertility Awareness Week® by Ringing the Nasdaq Stock Market Opening Bell and Lighting the Empire State Building
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, in its capacity as an official sponsor of National Infertility Awareness Week 2022, and...
Apr 18, 2022 09:00 am ET
Meritage Homes Names Malissia Clinton Its Executive Vice President, General Counsel and Secretary
Meritage Homes Corporation (NYSE:MTH), a leading U.S. homebuilder, today announced the hiring of Malissia Clinton as its executive vice president, general counsel and secretary. “We are pleased to welcome Malissia to Meritage Homes,” said...
Mar 30, 2022 09:51 pm ET
Moore Kuehn, PLLC Encourages Investors of PGNY, PTCT, GDOT, and RETA to Contact Law Firm
Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY), PTC Therapeutics, Inc. (NASDAQ: PTCT), Green Dot Corporation (NYSE: GDOT), and Reata...
Mar 10, 2022 09:30 am ET
Progyny, Inc. to Present at the Barclays Global Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston,...
Feb 28, 2022 04:05 pm ET
Progyny, Inc. Announces Fourth Quarter and Full Year 2021 Results
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three- and twelve-month periods ended December...
Feb 11, 2022 12:30 pm ET
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2021 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period and full year ended December 31,...
Jan 05, 2022 12:00 pm ET
Progyny, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will present at the...
Nov 04, 2021 04:05 pm ET
Progyny, Inc. Announces Third Quarter 2021 Results
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three-month period ended September 30, 2021...
Oct 21, 2021 03:30 pm ET
Progyny, Inc. Announces Details for Its Third Quarter 2021 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended September 30, 2021 after the...
Sep 10, 2021 12:00 pm ET
Progyny, Inc. to Present at the BofA Global Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Livingston,...
Aug 24, 2021 08:00 am ET
Castlight Health Expands Ecosystem with Four New Digital Health Partners
SAN FRANCISCO, Aug. 24, 2021 /PRNewswire/ -- Castlight Health, Inc. (NYSE: CSLT), a leader in healthcare navigation, announced today four new additions to its industry-leading digital health ecosystem. The new ecosystem partners will help address growing needs as the pandemic wears on and employers are faced with mounting health challenges in the workplace. Castlight's new ecosystem partners include:
Aug 06, 2021 12:00 pm ET
Progyny, Inc. to Present at the BofA Securities SMID Cap 2H21 Ideas Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, will participate in...
Aug 05, 2021 04:05 pm ET
Progyny, Inc. Announces Second Quarter 2021 Results
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three-month period ended June 30, 2021 (“the...
Jul 22, 2021 03:30 pm ET
Progyny, Inc. Announces Details for Its Second Quarter 2021 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended June 30, 2021 after the...
Jun 04, 2021 11:00 am ET
Progyny, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Livingston,...
May 26, 2021 09:00 am ET
Largest Research Study on Decision Making of Single or Coupled Intended Fathers Selected for Presentation at 2021 ACOG Annual Clinical and Scientific Meeting and 69th Annual Pacific Coast Reproductive
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, along with RMA of Connecticut, RMA of New York, and Stanford University partnered on the...
May 07, 2021 01:00 pm ET
Progyny, Inc. to Present at the BofA Securities 2021 Health Care Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Livingston,...
May 06, 2021 04:05 pm ET
Progyny, Inc. Announces First Quarter 2021 Results
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three-month period ended March 31, 2021 (“the...
Apr 22, 2021 02:05 pm ET
Progyny, Inc. Announces Details for Its First Quarter 2021 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended March 31, 2021 after the...
Feb 24, 2021 04:05 pm ET
Progyny, Inc. Announces Fourth Quarter and Full Year 2020 Results
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three- and twelve-month periods ended December...
Feb 22, 2021 11:00 am ET
Progyny, Inc. to Participate at the 10th Annual SVB Leerink Global Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Livingston,...
Feb 10, 2021 12:00 pm ET
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period and full year ended December 31,...
Jan 05, 2021 09:00 am ET
Progyny, Inc. to Present at the 39th Annual JP Morgan Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, will present at the...
Nov 18, 2020 08:00 am ET
Progyny Strengthens Board of Directors with Appointments of Healthcare and Technology Leaders
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced the appointment of two new members to its board of directors, effective...
Nov 16, 2020 12:00 pm ET
Progyny, Inc. Announces Participation at the Piper Sandler Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, will participate in...
Nov 05, 2020 04:05 pm ET
Progyny, Inc. Announces Third Quarter 2020 Results
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three-month period ended September 30, 2020...
Oct 22, 2020 12:04 pm ET
Progyny, Inc. Announces Details for Its Third Quarter Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended September 30, 2020 after the...
Oct 19, 2020 09:00 am ET
Progyny and RMA of New York Partner on Original Research Selected for Presentation at the 76th Annual ASRM Scientific Congress and Expo
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, and RMA of New York, a Manhattan-based fertility clinic, presented original research at the...
Sep 10, 2020 12:00 pm ET
Progyny, Inc. Announces Participation at the BofA Global Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, will participate in...
Sep 09, 2020 08:00 am ET
Progyny, Inc. Promotes Seasoned Executive Mark Livingston to Chief Financial Officer
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Mark Livingston, Progyny’s Executive Vice President of Finance, has been...
Aug 05, 2020 04:05 pm ET
Progyny, Inc. Announces Second Quarter 2020 Results
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three-month period ended June 30, 2020 (“the...
Jul 22, 2020 12:00 pm ET
Progyny, Inc. Announces Details for Its Second Quarter Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended June 30, 2020 after the...
Jun 04, 2020 11:58 am ET
Progyny, Inc. Announces Participation at the Goldman Sachs Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Pete Anevski,...
May 12, 2020 04:05 pm ET
Progyny, Inc. Announces First Quarter 2020 Results
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three-month period ended March 31, 2020 (“the...
May 05, 2020 02:00 pm ET
Progyny, Inc. to Present at the BofA Securities 2020 Health Care Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Pete Anevski,...
Apr 21, 2020 08:00 am ET
Progyny to Ring the Nasdaq Stock Market Opening Bell in Recognition of National Infertility Awareness Week®
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, announced today the company will virtually ring the Nasdaq Stock Market Opening Bell on April...
Apr 20, 2020 12:00 pm ET
Progyny, Inc. Announces Details for Its First Quarter Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended March 31, 2020 after the...
Mar 18, 2020 07:00 am ET
Progyny, Inc. Provides Update on Impact of COVID-19
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today provided an update on the impact of the COVID-19 pandemic on its business. As part of...
Mar 05, 2020 04:06 pm ET
Progyny, Inc. Announces Fourth Quarter and Full Year 2019 Results
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three- and twelve-month periods ended December...
Feb 20, 2020 04:00 pm ET
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period and full year ended December 31,...
Jan 06, 2020 09:00 am ET
Progyny, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced David Schlanger, Progyny’s Chief Executive Officer, will present at the 38th...
Dec 04, 2019 04:05 pm ET
Progyny, Inc. Announces Third Quarter 2019 Results
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three month period ended September 30, 2019...
Nov 18, 2019 03:30 pm ET
Progyny, Inc. Announces Details for Its Third Quarter Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended September 30, 2019 on...
Oct 29, 2019 05:05 pm ET
Progyny, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Progyny, Inc., a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced the closing of its initial public offering of 11,500,000 shares of its common stock,...
Oct 24, 2019 08:01 pm ET
Progyny, Inc. Announces Pricing of Initial Public Offering
Progyny, Inc., a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.